Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2005

Nov 10, 2005

33510_dirs_2005-11-10_410cc866-eb3d-4dfc-93b3-f9aaac389f78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISRY)
CIK: 0000728387
Period of Report: 2005-11-08

Reporting Person: Swanberg David (Director, V.P. Operations & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-11-08 Common Stock P 3000 $4 Acquired 300109 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-11-08 common sstock purchase warrant $6 P 3000 Acquired 2007-11-08 common stock (3000) Direct